7-Angelylretronecine

Details

Top
Internal ID ffa70864-a825-4caa-9a13-9a21725aa873
Taxonomy Alkaloids and derivatives
IUPAC Name [(1R,8R)-7-(hydroxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-1-yl] (Z)-2-methylbut-2-enoate
SMILES (Canonical) CC=C(C)C(=O)OC1CCN2C1C(=CC2)CO
SMILES (Isomeric) C/C=C(/C)\C(=O)O[C@@H]1CCN2[C@@H]1C(=CC2)CO
InChI InChI=1S/C13H19NO3/c1-3-9(2)13(16)17-11-5-7-14-6-4-10(8-15)12(11)14/h3-4,11-12,15H,5-8H2,1-2H3/b9-3-/t11-,12-/m1/s1
InChI Key TYGYPIIOOQNWBU-BTRLNGJCSA-N
Popularity 0 references in papers

Physical and Chemical Properties

Top
Molecular Formula C13H19NO3
Molecular Weight 237.29 g/mol
Exact Mass 237.13649347 g/mol
Topological Polar Surface Area (TPSA) 49.80 Ų
XlogP 0.50
Atomic LogP (AlogP) 0.87
H-Bond Acceptor 4
H-Bond Donor 1
Rotatable Bonds 3

Synonyms

Top
6029-82-9
7-Angeloylretronecine
CCRIS 4337
UNII-9B793GX6WI
9B793GX6WI
[(1R,8R)-7-(hydroxymethyl)-2,3,5,8-tetrahydro-1H-pyrrolizin-1-yl] (Z)-2-methylbut-2-enoate
O-7-ANGELYLRETRONECINE
RETRONECINE, 1-ANGELATE
DTXSID70209043
AKOS040761240
There are more than 10 synonyms. If you wish to see them all click here.

2D Structure

Top
2D Structure of 7-Angelylretronecine

3D Structure

Top

ADMET Properties (via admetSAR 2)

Top
Target Value Probability (raw) Probability (%)
Human Intestinal Absorption + 0.9686 96.86%
Caco-2 + 0.8310 83.10%
Blood Brain Barrier + 0.7250 72.50%
Human oral bioavailability - 0.5714 57.14%
Subcellular localzation Mitochondria 0.6671 66.71%
OATP2B1 inhibitior - 0.8578 85.78%
OATP1B1 inhibitior + 0.9235 92.35%
OATP1B3 inhibitior + 0.9480 94.80%
MATE1 inhibitior - 0.8021 80.21%
OCT2 inhibitior - 0.5250 52.50%
BSEP inhibitior - 0.8113 81.13%
P-glycoprotein inhibitior - 0.9669 96.69%
P-glycoprotein substrate - 0.7257 72.57%
CYP3A4 substrate + 0.5120 51.20%
CYP2C9 substrate - 0.8000 80.00%
CYP2D6 substrate - 0.7533 75.33%
CYP3A4 inhibition - 0.9646 96.46%
CYP2C9 inhibition - 0.8902 89.02%
CYP2C19 inhibition - 0.8878 88.78%
CYP2D6 inhibition - 0.8283 82.83%
CYP1A2 inhibition - 0.6621 66.21%
CYP2C8 inhibition - 0.9461 94.61%
CYP inhibitory promiscuity - 0.8278 82.78%
UGT catelyzed - 0.7638 76.38%
Carcinogenicity (binary) - 0.9700 97.00%
Carcinogenicity (trinary) Non-required 0.5050 50.50%
Eye corrosion - 0.9654 96.54%
Eye irritation - 0.9793 97.93%
Skin irritation - 0.7509 75.09%
Skin corrosion - 0.8580 85.80%
Ames mutagenesis - 0.8154 81.54%
Human Ether-a-go-go-Related Gene inhibition - 0.5272 52.72%
Micronuclear + 0.5700 57.00%
Hepatotoxicity + 0.9875 98.75%
skin sensitisation - 0.8294 82.94%
Respiratory toxicity + 0.6556 65.56%
Reproductive toxicity + 0.5556 55.56%
Mitochondrial toxicity + 0.7375 73.75%
Nephrotoxicity + 0.6228 62.28%
Acute Oral Toxicity (c) III 0.6107 61.07%
Estrogen receptor binding - 0.9415 94.15%
Androgen receptor binding - 0.6600 66.00%
Thyroid receptor binding - 0.5606 56.06%
Glucocorticoid receptor binding - 0.6066 60.66%
Aromatase binding - 0.8409 84.09%
PPAR gamma - 0.7875 78.75%
Honey bee toxicity - 0.8934 89.34%
Biodegradation - 0.5500 55.00%
Crustacea aquatic toxicity - 0.6655 66.55%
Fish aquatic toxicity - 0.8091 80.91%

Targets

Top

Proven Targets:

CHEMBL ID UniProt ID Name Min activity Assay type Source
No proven targets yet!

Predicted Targets (via Super-PRED):

CHEMBL ID UniProt ID Name Probability Model accuracy
CHEMBL3251 P19838 Nuclear factor NF-kappa-B p105 subunit 97.79% 96.09%
CHEMBL2581 P07339 Cathepsin D 90.93% 98.95%
CHEMBL5619 P27695 DNA-(apurinic or apyrimidinic site) lyase 87.07% 91.11%
CHEMBL5608 Q16288 NT-3 growth factor receptor 84.44% 95.89%
CHEMBL3108638 O15164 Transcription intermediary factor 1-alpha 82.61% 95.56%
CHEMBL4203 Q9HAZ1 Dual specificity protein kinase CLK4 81.21% 94.45%
CHEMBL3807 P17706 T-cell protein-tyrosine phosphatase 80.19% 93.00%

Cross-Links

Top
PubChem 6440943
NPASS NPC200620
LOTUS LTS0127170
wikiData Q27272305